NEUP vs PHM · rev $15.7M vs P/E 7.7, rev $7.39B
Neuphoria Therapeutics Inc (NEUP) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.
Latest reported PHM revenue for 2026-06-30 was $7.39B. Net income was $819.0M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
NEUP currently screens at market cap $23.6M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the NEUP and PHM stock pages for the full models.
Not investment advice.